Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe
Open Access
Abstract
In this review the authors aimed to emphasize the practical value of nuclear expression of the mammary serine protease inhibitor (maspin), also known as serpin B5 protein, in colorectal carcinoma (CRC), from pre-malignant disorders to carcinogenesis and metastasis. As the role of maspin is controversial and not yet understood, the present update highlights the latest data revealed by literature which were filtrated through the daily experience of the authors, which was gained at microscopic examination of maspin expression in CRCs and other tumors for daily diagnosis. Data regarding the subcellular localization of maspin, in correlation with the microsatellite status, grade of tumor dedifferentiation, and epithelial-mesenchymal transition (EMT) phenomenon of the tumor buds were presented with details. An original observation refers to the maspin capacity to mark the tumor cells which are “at the point of budding” that were previously considered as having “hybrid EMT phenotype”. It refers to the transitional status of tumor cell that is between “epithelial status” and “mesenchymal status”. The second original hypothesis highlights the possible role of maspin in dysregulating the intestinal microbiota, in patients with idiopathic inflammatory bowel diseases (IBD) and inducing IBD-related CRC. The dynamic process of budding and EMT of tumor buds, possible mediated by maspin, needs further investigation and validation in many human CRC samples. The histological and molecular data reveal that synthesis of maspin-based therapeutics might represent a novel individualized therapeutic strategy for patients with CRC.Keywords
Funding Information
- Autoritatea Natională pentru Cercetare Stiintifică (PCCF 20/2018)
This publication has 67 references indexed in Scilit:
- Maspin expression and melanoma progression: a matter of sub-cellular localizationLaboratory Investigation, 2014
- Role of maspin in cancerClinical and Translational Medicine, 2013
- Serrated Pathway Adenocarcinomas: Molecular and Immunohistochemical Insights into Their RecognitionPLOS ONE, 2013
- The Possible Role of Mena Protein and Its Splicing-Derived Variants in Embryogenesis, Carcinogenesis, and Tumor Invasion: A Systematic Review of the LiteratureBioMed Research International, 2013
- Maspin: molecular mechanisms and therapeutic implicationsCancer and Metastasis Reviews, 2012
- Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of HypoxiaPLOS ONE, 2012
- Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutationsPathology - Research and Practice, 2012
- Tyrosine phosphorylation plays a role in increasing maspin protein levels and its cytoplasmic accumulationFEBS Open Bio, 2012
- Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node‐positive colonic cancerHistopathology, 2010
- Functional implications of the modeled structure of maspinProtein Engineering, Design and Selection, 1996